ScholarLens Back to search
2008•Journal of the International AIDS SocietyOpen access

Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients

Benjamin Young, E DeJesus, JO Morales-Ramirez, Ramin Ebrahimi, JF Maa, Damian J. McColl, Awny Farajallah, Daniel Seekins, J.F. Flaherty

Open full text 1 citations

Abstract

Purpose of the studyAI266073 is a 48-week, randomized, open-label, multicenter study with the primary objective of evaluating noninferiority of simplification of ART to efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF) vs. continuation of the same baseline regimen (SBR) unmodified.from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK.

Open-access reader

About this research paper

What this paper is about

Purpose of the studyAI266073 is a 48-week, randomized, open-label, multicenter study with the primary objective of evaluating noninferiority of simplification of ART to efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF) vs. continuation of the same baseline regimen (SBR) unmodified.from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose of the studyAI266073 is a 48-week, randomized, open-label, multicenter study with the primary objective of evaluating noninferiority of simplification of ART to efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF) vs. continuation of the same baseline regimen (SBR) unmodified.from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK.

Key concepts: Emtricitabine, Efavirenz, Medicine, Tenofovir, Regimen, Antiretroviral therapy, Human immunodeficiency virus (HIV), Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients — Research Paper | ScholarLens